Peer-reviewedCC BY 4.0iScience
Lactate as a predictive biomarker and therapeutic target in cardiopulmonary bypass-associated acute kidney injury
Related
- Integrated Transcriptomic Analysis Identifies ENO3 as a Candidate Lactate Metabolism‐Associated Biomarker in Colorectal Cancer Metastasis
- Granzyme B as a predictive biomarker for therapeutic outcomes in non-small cell lung cancer patients undergoing anti-PD-1 therapy
- A predictive model for adverse events in left heart failure patients based on cardiopulmonary ultrasound parameters and clinical predictors
- Brief Report: Reassessment of bTMB as a Predictive Biomarker in NSCLC Immunotherapy—A Reanalysis of OAK and POPLAR
- Lactate and lactylation: mechanisms, function, diseases, and therapeutic targets
BibTeX
@article{xue2026lactate,
title = {{Lactate as a predictive biomarker and therapeutic target in cardiopulmonary bypass-associated acute kidney injury}},
author = {Dinghao Xue and Mingru Zhang and Xinlu Chang and Tianlong Wang and Bingyang Ji and Chunhua Xi and Guyan Wang},
journal = {iScience},
year = {2026},
month = oct,
doi = {10.1016/j.isci.2026.117643},
url = {https://www.cell.com/iscience/fulltext/S2589-0042(26)03024-5},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Lactate as a predictive biomarker and therapeutic target in cardiopulmonary bypass-associated acute kidney injury
AU - Dinghao Xue
AU - Mingru Zhang
AU - Xinlu Chang
AU - Tianlong Wang
AU - Bingyang Ji
AU - Chunhua Xi
AU - Guyan Wang
PY - 2026
DA - 2026/10/07
JO - iScience
DO - 10.1016/j.isci.2026.117643
UR - https://www.cell.com/iscience/fulltext/S2589-0042(26)03024-5
SN - 2589-0042
ER -